N/A
Completed N=255
This is a Retrospective Observational Study Looking at the Characteristics and Outcomes of Participants Taking Inflectra Using the CorEvitas Rheumatoid Arthritis Registry
Arthritis, Rheumatoid
Source: ClinicalTrials.gov NCT05375942 ↗
Enrolled (actual)
255
Serious AEs
—
Results posted
Apr 2024
Primary outcomePrimary: Percentage of Participants Who Achieved Low Disease Activity (LDA) at 6 Months After Inflectra Initiation — 32.9 Percentage of participants
Summary
This is a retrospective observational study looking at the characteristics and outcomes of participants taking Inflectra using the CorEvitas Rheumatoid Arthritis Registry.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Percentage of Participants Who Achieved Low Disease Activity (LDA) at 6 Months After Inflectra Initiation |
32.9 | — |
| SECONDARY Percentage of Participants Who Achieved Clinical Remission at 6 Months After Inflectra Initiation |
13.7 | — |
| SECONDARY Change From Baseline in CDAI at 6 Months After Inflectra Initiation |
-1.8 | — |
| SECONDARY Change From Baseline in Health Assessment Questionnaire (HAQ) at 6 Months After Inflectra Initiation |
-0.0 | — |
| SECONDARY Change From Baseline in Participant Pain Assessment at 6 Months After Inflectra Initiation |
-0.5 | — |
| SECONDARY Change From Baseline in Participant Fatigue Assessment at 6 Months After Inflectra Initiation |
-1.4 | — |
| SECONDARY Percentage of Participants With a Modified American College of Rheumatology 20 Percent (%) (mACR20) Response at 6 Months After Inflectra Initiation |
12.6 | — |
| SECONDARY Percentage of Participants With mACR50 at 6 Months After Inflectra Initiation |
8.4 | — |
| SECONDARY Percentage of Participants With mACR70 at 6 Months After Inflectra Initiation |
4.2 | — |
Eligibility Criteria
Inclusion Criteria
- Be at least 18 years of age
- Have been diagnosed with RA by a rheumatologist
- Have initiated treatment with Inflectra
- Had assessment of effectiveness in patients who have at least one follow up visit.
Exclusion Criteria
- No additional exclusion criteria
Data sourced from ClinicalTrials.gov (NCT05375942). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.